Translational Head and Neck Cancer Genomics | Mass Eye and Ear | Harvard Medical School
Boston, MA
Joined September 2021
- Tweets230
- Following389
- Followers464
- Likes501
Great trip to Kyoto for the AACR-JCA meeting. Wonderful to see old friends and make new ones. Thank you to @AACR and outgoing AACR president @lillian_siu for the invitation to speak on our work advancing liquid biopsy - and the late night yakitori, chicken hearts, liver and all.
And last but not least, I was truly surprised (and touched) by the cake and champagne celebrating my recent promotion to Associate Professor at Harvard Medical School. It’s an honor to work with, teach, and learn from such remarkable people.
@MGBResearchNews
@MassGenBrigham
5
130
I’m also deeply thankful for an outstanding lab and collaborators here in Boston—who led a terrific journal club last night on emerging ctDNA trials, co-hosted with Viktor Adalsteinsson and his team @broadinstitute.
1
3
141
2026 lab photo — hard to believe how far we’ve come in six years, growing from a lab of one into the team we are today. Proud of the impactful work this group continues to produce, but equally proud of the culture of collaboration.
5
274
Privileged to participate in the @SU2C summit on oropharynx and anal cancer early detection. Great exchange of ideas and hopeful for the advancements to come.
In a wide-ranging #SU2CInnovationSummit, scientists from many different fields discussed methods, technologies, and systems for catching cancers at their earliest stages and selecting the best treatments for every patient. #StandUpToCancer
Despite all the challenges right now, nothing makes me prouder than learning that while I was in Germany presenting our lab’s work, the lab got together on their own to celebrate birthdays and personal milestones. Grants, papers, and keynotes are great—but this is what it’s about
4
143
Thank you to @DavidRoutmanMD and @aadel_chaudhuri for the beautifully written commentary in @JNCI_Now summarizing our recent HPV-DeepSeek manuscript demonstrating that HPV+ oropharynx cancer can be detected in the blood years before clinical diagnosis. Link to both articles below
Great day for a little team building at the @MGBResearchNews Cancer 5K!
@MassGeneralNews @MassEyeAndEar
Excited to share our new manuscript, Circulating tumor HPV DNA whole genome sequencing enables HPV+oropharynx cancer early detection published in @JNCI_Now. Congrats to first author @dipondas30 and the full study team @MassEyeAndEar, @broadinstitute, @MGHCancerCenter
Our simultaneously published manuscripts describing two custom whole genome sequencing liquid biopsy approaches are now available to read online in @CCR_AACR
HPV-DeepSeek (HPV WGS): aacrjournals.org/clincancerr…
MAESTRO (Human WGS): aacrjournals.org/clincancerr…
In two new @CCR_AACR publications, researchers from @MassEyeAndEar, @MGHCancerCenter and colleagues developed a blood test that shows superior sensitivity in detecting HPV-associated head and neck cancer.
Read more: massgeneralbrigham.org/en/ab… @FadenLab @broadinstitute
Outstanding talks & discussion from so many leaders in the field like Viktor Adalsteinsson @broadinstitute (below). The pace of technology development makes it clear LB will continue to revolutionize cancer screening, diagnostics & monitoring. Honored to participate & contribute
The final day of the AACR Special Conference on Liquid Biopsy will feature sessions on computational science as well as liquid biopsy and immunotherapy. #aacrLBx24
3
394
It's not just oropharynx........
25% of nasopharyngeal cancers are now caused by HPV in North America 😯. Nice work @brianyzhao.
sciencedirect.com/science/ar…
Outstanding week in Taiwan on behalf of the Taiwan Head and Neck Society at the annual meeting of the THNS in Taipei and next at the Veterans General Hospital in Kaohsiung. Exceptional hosts, scientific discussion and cross-continental collaboration. Can't wait to return.
1
6
448
Patients with MRD after treatment completion were more likely to experience recurrence (3/3 vs 0/29) and had a shorter time to death. Lead times from MRD to clinical detection of recurrence ranged from 56-415 days.
1
2
248
Congrats to @jjmpremed on winning our lab PuttPutt tournament! Fun times as we say goodbye to Alan as he returns to Shanghai and wish happy birthday to Valeza.
